https://www.selleckchem.com/products/ipa-3.html
There was no significant difference in 90-day mortality when comparing both PDS approach (10% vs 8.4%, P = .257). This remained unchanged in a multivariable model after adjusting for risk factors (odds ratio1.32 [95%CI0.91-1.93] [P = .14]). Reoperation due to infection was less in FocA (0.5%) vs CompA (2.6) (P .001) and postoperative septicemia was increased in the FocA (1.7%) cohort when compared to the CompA (0.7%) (P .001) patients. There was no difference in post valve surgery 90-day mortality between patients who underwent
Like
Comment
Share
